This inventor holds 130 USPTO granted patents and 76 published patent applications and 1 EPO patent, primarily in Light Therapy Devices (CPC class A61N2005-0652). Top assignees: Shenzhen Kaiyan Medical Equipment Co., Ltd., Shenzhen Oren Medical Technology Co, Ltd, Shenzhen Rainbow Light Medical Equipment Co., Ltd.. Active years: 2017-2026.
Inventors with similar research interests:
Location History:
- Shenzhen, CN (2017)
- Amstelveen, NL (2021 - 2024)
- Eindhoven, NL (2024)
Company Filing History:
30 out of 30 
11 out of 11 
10 out of 13 
Years Active: 2017-2026
Areas of Expertise:
Title: Innovations by Alain Dijkstra: A Spotlight on His Vision-Enhancing Patents
Introduction
Alain Dijkstra, a prominent inventor based in Amstelveen, Netherlands, holds an impressive portfolio of 23 patents. His dedication to advancing vision therapy technology has led to the development of innovative devices aimed at improving visual health.
Latest Patents
One of Dijkstra's latest breakthrough inventions is a device for vision training and therapy. This device features a spectacle frame designed with left and right rims that incorporate multiple therapeutic light sources. These light sources provide essential light therapy directly to the eyes of the user. Additionally, the device includes a longitudinal member extending along the user’s line of sight, equipped with a plurality of colored light sources connected by a white stripe, making it viewable by both eyes. A controller is also integrated to manage the therapeutic and colored light sources, while the longitudinal member can be extended through an extension mechanism attached to the spectacle frame.
Career Highlights
Throughout his career, Alain Dijkstra has contributed significantly to the field of vision therapy. His inventive spirit and technical expertise have made a lasting impact on the industry.
Collaborations
Dijkstra has collaborated with various professionals, including Yvonne Johanna Margaretha Houthuijs and Jonathan James Knight. His connections within the industry have fostered innovation and advancement in vision-related technologies. Furthermore, he has worked with companies such as Lumi Ceuticals, LLC, where his contributions have been pivotal to their mission.
Conclusion
Alain Dijkstra's achievements in the realm of vision therapy are commendable, showcasing a remarkable blend of innovation and dedication. His latest patents not only reflect his creativity but also hold the potential to significantly enhance visual training and therapy for users, paving the way for future advancements in this crucial field.